Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Fang, Jia H ^a,b   Wang, Xing H ^a   Xu, Zhi R ^a   Jiang, Fa G ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b YANGTZE UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(7) TACRINE; FLUORESCEIN ISOTHIOCYANATE; FLUOROGOLD; GLUTAMIC ACID; LIPOCORTIN 5; MEMANTINE; PROPIDIUM IODIDE; TACRINE DERIVATIVE; UNCLASSIFIED DRUG; 1,7 N HEPTYLENE BIS 9,9' AMINO 1,2,3,4 TETRAHYDROACRIDINE; 1,7-N-HEPTYLENE-BIS-9,9'-AMINO-1,2,3,4-TETRAHYDROACRIDINE; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; TACRINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CELL LABELING; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG POTENCY; EXCITOTOXICITY; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; RAT; RETINA GANGLION CELL; SPRAGUE DAWLEY RAT; ANIMAL; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; TIME;

ANIMALS; APOPTOSIS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; INHIBITORY CONCENTRATION 50; MALE; MEMANTINE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; TACRINE; TIME FACTORS;

EID: 77950386123     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-31     Document Type: Article

References (51)

1. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 1957, 58(2):193-201.
2. Thoreson WB, Witkovsky P. Glutamate receptors and circuits in the vertebrate retina. Prog Retin Eye Res 1999, 18(6):765-810. 10.1016/S1350-9462(98)00031-7, 10530751.
3. Yu W, Miller RF. The mechanism by which NBQX enhances NMDA currents in retinal ganglion cells. Brain Res 1996, 709(2):184-196. 10.1016/0006-8993(95)01285-0, 8833754.
4. Sonkusare SK, Kaul CL, Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope. Pharmacol Res 2005, 51(1):1-17.
5. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997, 37(24):3483-3493. 10.1016/S0042-6989(97)00047-3, 9425525.
6. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004, 23(1):91-147. 10.1016/j.preteyeres.2003.12.001, 14766318.
7. Dreyer EB. A proposed role for excitotoxicity in glaucoma. J Glaucoma 1998, 7(1):62-67. 10.1097/00061198-199802000-00012, 9493118.
8. Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am 2005, 18(3):383-395. vi, 10.1016/j.ohc.2005.04.002, 16054996.
9. Pang IH, Zeng H, Fleenor DL, Clark AF. Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci 2007, 8:11. 10.1186/1471-2202-8-11, 1794249, 17261189.
10. Inomata Y, Hirata A, Yonemura N, Koga T, Kido N, Tanihara H. Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage. Biochem Biophys Res Commun 2003, 302(2):226-232. 10.1016/S0006-291X(03)00127-X, 12604335.
11. Calzada JI, Jones BE, Netland PA, Johnson DA. Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers. Neurochem Res 2002, 27(1-2):79-88. 10.1023/A:1014854606309, 11926279.
12. Levin LA, Peeples P. History of neuroprotection and rationale as a therapy for glaucoma. Am J Manag Care 2008, 14(1 Suppl):S11-14.
13. Lipton SA. Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv Ophthalmol 2003, 48(Suppl 1):S38-46. 10.1016/S0039-6257(03)00008-0, 12852433.
14. Fatma N, Kubo E, Sen M, Agarwal N, Thoreson WB, Camras CB, Singh DP. Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca(2+) homeostasis. Brain Res 2008, 3;1233:63-78.
15. Brooks DE, Garcia GA, Dreyer EB, Zurakowski D, Franco-Bourland RE. Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res 1997, 58(8):864-867.
16. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996, 114(3):299-305.
17. Levin LA. Retinal ganglion cells and neuroprotection for glaucoma. Surv Ophthalmol 2003, 48(Suppl 1):S21-24. 10.1016/S0039-6257(03)00007-9, 12852431.
18. Nagata T, Ueno S, Morita H, Kubota T, Toyohira Y, Tsutsui M, Tawara A, Yanagihara N. Direct inhibition of N-methyl-D-aspartate (NMDA)-receptor function by antiglaucomatous beta-antagonists. J Pharmacol Sci 2008, 106(3):423-434. 10.1254/jphs.FP0071776, 18319565.
19. Osborne NN. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmol 2009, 87(4):450-454. 10.1111/j.1755-3768.2008.01459.x, 19141144.
20. Molinaro G, Battaglia G, Riozzi B, Di Menna L, Rampello L, Bruno V, Nicoletti F. Memantine treatment reduces the expression of the K(+)/Cl(-) cotransporter KCC2 in the hippocampus and cerebral cortex, and attenuates behavioural responses mediated by GABA(A) receptor activation in mice. Brain Res 2009, 1265:75-79. 10.1016/j.brainres.2009.02.016, 19236854.
21. Danesh-Meyer HV, Levin LA. Neuroprotection: extrapolating from neurologic diseases to the eye. Am J Ophthalmol 2009, 148(2):186-191. 10.1016/j.ajo.2009.03.029, 19464671.
22. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999, 30(12):2752-2758.
23. Zhao Y, Li W, Chow PC, Lau DT, Lee NT, Pang Y, Zhang X, Wang X, Han Y. Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia. Neurosci Lett 2008, 439(2):160-164. 10.1016/j.neulet.2008.05.007, 18515007.
24. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993, 115(5):608-613.
25. Kanellopoulos AJ, Erickson KA, Netland PA. Systemic calcium channel blockers and glaucoma. J Glaucoma 1996, 5(5):357-362. 10.1097/00061198-199610000-00011, 8897236.
26. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 1999, 96(17):9944-9948. 10.1073/pnas.96.17.9944, 22315, 10449799.
27. Neufeld AH. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res Bull 2004, 62(6):455-459. 10.1016/j.brainresbull.2003.07.005, 15036557.
28. Pang YP, Quiram P, Jelacic T, Hong F, Brimijoin S. Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J Biol Chem 1996, 271(39):23646-23649. 10.1074/jbc.271.39.23646, 8798583.
29. Wang H, Carlier PR, Ho WL, Wu DC, Lee NT, Li CP, Pang YP, Han YF. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE. Neuroreport 1999, 10(4):789-793.
30. Li W, Pi R, Chan HH, Fu H, Lee NT, Tsang HW, Pu Y, Chang DC, Li C, Luo J, et al. Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors. J Biol Chem 2005, 280(18):18179-18188. 10.1074/jbc.M411085200, 15710623.
31. Li W, Mak M, Jiang H, Wang Q, Pang Y, Chen K, Han Y. Novel Anti-Alzheimer's Dimer Bis(7)-Cognitin: Cellular and Molecular Mechanisms of Neuroprotection Through Multiple Targets. Neurotherapeutics 2009, 6(1):187-201. 10.1016/j.nurt.2008.10.040, 19110209.
32. Li W, Lee NT, Fu H, Kan KK, Pang Y, Li M, Tsim KW, Li X, Han Y. Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrine. Neuroreport 2006, 17(5):471-474. 10.1097/01.wnr.0000209014.09094.72, 16543809.
33. Fu H, Li W, Lao Y, Luo J, Lee NT, Kan KK, Tsang HW, Tsim KW, Pang Y, Li Z, et al. Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels. J Neurochem 2006, 98(5):1400-1410. 10.1111/j.1471-4159.2006.03960.x, 16771827.
34. Liu YW, Li CY, Luo JL, Li WM, Fu HJ, Lao YZ, Liu LJ, Pang YP, Chang DC, Li ZW, et al. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors. Biochem Biophys Res Commun 2008, 369(4):1007-1011. 10.1016/j.bbrc.2008.02.133, 18328812.
35. Luo J, Li W, Liu Y, Zhang W, Fu H, Lee NT, Yu H, Pang Y, Huang P, Xia J, et al. Novel dimeric bis(7)-tacrine proton-dependently inhibits NMDA-activated currents. Biochem Biophys Res Commun 2007, 361(2):505-509. 10.1016/j.bbrc.2007.07.043, 17655827.
36. Otori Y, Wei JY, Barnstable CJ. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci 1998, 39(6):972-981.
37. Linden R, Esberard CE. Displaced amacrine cells in the ganglion cell layer of the hamster retina. Vision Res 1987, 27(7):1071-1076. 10.1016/0042-6989(87)90021-6, 3660661.
38. Kawasaki A, Han MH, Wei JY, Hirata K, Otori Y, Barnstable CJ. Protective effect of arachidonic acid on glutamate neurotoxicity in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2002, 43(6):1835-1842.
39. Li W, Xue J, Niu C, Fu H, Lam CS, Luo J, Chan HH, Xue H, Kan KK, Lee NT, et al. Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase. Mol Pharmacol 2007, 71(5):1258-1267. 10.1124/mol.106.029108, 17299028.
40. Kawasaki A, Otori Y, Barnstable CJ. Muller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity. Invest Ophthalmol Vis Sci 2000, 41(11):3444-3450.
41. Li Z, Hua Y, Ming LW, Chun CM, Ping PY, Ge L, Tao WY, Zhong Z, Fan HY. Selective and sensitive determination of bis(7)-tacrine, a high erythrocyte binding acetylcholinesterase inhibitor, in rat plasma by high-performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2008, 22(4):414-420. 10.1002/bmc.949, 18059054.
42. Yu H, Ho JM, Kan KK, Cheng BW, Li WM, Zhang L, Lin G, Pang YP, Gu ZM, Chan K, et al. Development of a high performance liquid chromatography-tandem mass method for determination of bis(7)-tacrine, a promising anti-Alzheimer's dimer, in rat blood. J Pharm Biomed Anal 2007, 44(5):1133-1138. 10.1016/j.jpba.2007.05.028, 17628383.
43. Brandstatter JH, Hartveit E, Sassoe-Pognetto M, Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci 1994, 6(7):1100-1112. 10.1111/j.1460-9568.1994.tb00607.x, 7952290.
44. Costenla AR, De Mendonca A, Sebastiao A, Ribeiro JA. An adenosine analogue inhibits NMDA receptor-mediated responses in bipolar cells of the rat retina. Exp Eye Res 1999, 68(3):367-370. 10.1006/exer.1998.0645, 10079145.
45. Muir KW, Grosset DG. Neuroprotection for acute stroke: making clinical trials work. Stroke 1999, 30(1):180-182.
46. Hickenbottom SL, Grotta J. Neuroprotective therapy. Semin Neurol 1998, 18(4):485-492. 10.1055/s-2008-1040901, 9932619.
47. Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J Neurosci 2006, 23(10):2611-2622. 10.1111/j.1460-9568.2006.04787.x, 16817864.
48. Gilling KE, Jatzke C, Hechenberger M, Parsons CG. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors. Neuropharmacology 2009, 56(5):866-875. 10.1016/j.neuropharm.2009.01.012, 19371579.
49. Chen HS, Lipton SA. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol 1997, 499(Pt 1):27-46. 1159335, 9061638.
50. Liu J, Ho W, Lee NT, Carlier PR, Pang Y, Han Y. Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats. Neurosci Lett 2000, 282(3):165-168. 10.1016/S0304-3940(00)00905-8, 10717417.
51. Liu YW, Luo JL, Ren H, Peoples RW, Ai YX, Liu LJ, Pang YP, Li ZW, Han YF, Li CY. Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies. Neuropharmacology 2008, 54(7):1086-1094. 10.1016/j.neuropharm.2008.02.015, 18407299.